Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon ...
Sign up for Being Human, a newsletter that explores wellness culture, mortality and disease, and other mysteries of the body and the mind. “It’s a branding ...
This scoping review followed guidelines recommended by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews. Published manuscripts from database ...
Damaging variants in genes involved in a rapid immune response (innate immunity) are significantly linked to earlier breast cancer onset in carriers of the harmful BRCA1 genetic mutation, reveal ...
In January 2022, when I was 32, I spit into a tube for genetic testing. Rather than mail the tube off to 23andMe or another ancestry service, I FedExed my saliva to Ambry Genetics, a company that ...
SEATTLE — The BRCA gene is commonly recognized for its link to breast and ovarian cancer risk among women. Mutations in BRCA1 and BRCA2 have been associated with increased risk for the cancers, but ...
Researchers at the University of Cambridge have created the world's largest catalog of human breast cells, which has revealed early cell changes in healthy carriers of BRCA1 and BRCA2 gene mutations.
Patients with prostate cancer may have an inherited or acquired BRCA mutation, and both can have treatment implications, an expert said. It is important for patients with prostate cancer to know if ...
Integrating new AI screening tools for BRCA and HRD breast-cancer mutations into routine care could lead to earlier detection, more precise treatment, and lives saved. If they are aware of the threat, ...
Researchers for the first time have identified dysfunctional immune cells in the healthy breast tissue of women with mutations in the genes BRCA1 and BRCA2, a finding that opens up the possibility of ...
Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among the large number of variants of uncertain significance (VUS) detected in ...